Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
P3 Health PartnersPIIIW +41.54%51 Debt-to-EBITDA is 0.71 as of Jun. 2026. GuruFocus rates PIIIW with a GF Score™ of 51/100. The stock has 7 warning signs investors should review. Among 480 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 208333.13% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for P3 Health Partners's Debt-to-EBITDA or its related term are showing as below:
PIIIW'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.75 Med: -1.25 Max: -0.07
Current: -1.59
During the past 8 years, the highest Debt-to-EBITDA Ratio of P3 Health Partners was -0.07. The lowest was -1.75. And the median was -1.25.
PIIIW's Debt-to-EBITDA is ranked worse than 100% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs PIIIW: -1.59
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
P3 Health Partners Debt-to-EBITDA Related Terms
P3 Health Partners Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PIIIW vs DCGO, CCEL, BTMD: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
P3 Health Partners (PIIIW) has a Debt-to-EBITDA of 0.71 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on P3 Health Partners. According to the industry distribution chart, P3 Health Partners ranks #999999 out of 480 companies in the Healthcare Providers & Services industry.
Is P3 Health Partners' Debt-to-EBITDA too high?
P3 Health Partners' current Debt-to-EBITDA is 0.71. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. P3 Health Partners' value of 0.71 is 67.5% below this industry median. Based on the distribution chart, P3 Health Partners ranks #999999 out of 480 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' Debt-to-EBITDA compare to DCGO and CCEL?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #999999 out of 480 companies for Debt-to-EBITDA. This places P3 Health Partners in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. P3 Health Partners' value of 0.71 is 67.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. P3 Health Partners's current Debt-to-EBITDA of 0.71 is 67.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on P3 Health Partners. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current Debt-to-EBITDA is 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
P3 Health Partners (PIIIW) has a current Debt-to-EBITDA of 0.71. The current Debt-to-EBITDA is 0.71 and 67.5% below the Healthcare Providers & Services industry median of 2.19. P3 Health Partners' overall GF Score™ is 51/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For P3 Health Partners (PIIIW), the current Debt-to-EBITDA is 0.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
51GF Score
Get the complete analysis for PIIIW
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIIIW has been successfully added to your 
